Howe Jill Ann
Insider CIK 1892397 · PROG Director · LCTX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2026-03-05 | 2026-03-06 | 1,050,000 | — | $0 | 1,050,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2025-03-10 | 2025-03-12 | 750,000 | — | $0 | 750,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | P Buy | 2024-11-26 | 2024-11-26 | 15,000 | $0.59 | $8.8K | 25,500 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | P Buy | 2024-08-16 | 2024-08-19 | 10,500 | $0.89 | $9.3K | 10,500 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | A Award deriv | 2024-06-05 | 2024-06-06 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | A Award | 2024-06-05 | 2024-06-06 | 12,500 | — | $0 | 31,916 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2024-03-07 | 2024-03-08 | 650,000 | — | $0 | 650,000 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | A Award deriv | 2023-06-14 | 2023-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | A Award | 2023-06-14 | 2023-06-16 | 12,500 | — | $0 | 19,416 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2023-03-09 | 2023-03-10 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | D To issuer | 2023-01-03 | 2023-01-05 | 19 | — | $0 | 0 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2022-11-14 | 2022-11-16 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | A Award deriv | 2022-06-15 | 2022-06-17 | 148,810 | — | $0 | 148,810 | SEC↗ |
| BIOR BIORA THERAPEUTICS, INC. | A Award | 2022-06-15 | 2022-06-17 | 96,154 | — | $0 | 172,908 | SEC↗ |
| PROG PROGENITY, INC. | A Award deriv | 2021-11-03 | 2021-11-05 | 82,879 | — | $0 | 82,879 | SEC↗ |
| PROG PROGENITY, INC. | A Award | 2021-11-03 | 2021-11-05 | 76,754 | — | $0 | 76,754 | SEC↗ |